Health care stocks were mixed in late Tuesday trading, with the NYSE Health Care Index rising about 0.1%, overcoming a mid-day decline, while the SPDR Health Care Select Sector ETF was less than 0.1% lower. The Nasdaq Biotechnology index was 0.1% higher this afternoon. In company news, Axsome Therapeutics (AXSM) declined 5% after the specialty drugmaker Tuesday said it secured a $225 million term loan from Hercules Capital (HTGC) and will use the proceeds will support the upcoming commercial launches of its AXS-05 prospective treatment for major depressive disorder and its AXS-07 drug candidate for migraines.
Upgrade to Premium and Analyze Stocks Like a Pro
50% Off All Subscriptions